You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 7, April 8, 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Herpes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Epstein-Barr Viral Load Assessment in Immunocompetent Patients With Fulminant Infectious Mononucleosis

Jan A. M. van Laar, MD, PhD; Corinne M. P. Buysse, MD; Ann C. T. M. Vossen, MD, PhD; Björn Hjálmarsson, MD; Bart van den Berg, MD, PhD; Kirsten van Lom, PhD; Jaap Deinum, MD, PhD

Arch Intern Med. 2002;162:837-839.

We describe 2 immunocompetent adolescents with fulminant infectious mononucleosis and virus-associated hemophagocytosis. A new quantitative polymerase chain reaction revealed high serum Epstein-Barr virus DNA levels in these patients. One patient died with an increasing viral load not responding to corticosteroids followed by antiviral and intensified immunomodulatory treatment. The other patient received corticosteroids and acyclovir at diagnosis; her rapid recovery was heralded by a steep decline of viral load. We propose monitoring the clinical course of fulminant infectious mononucleosis in immunocompetent patients by Epstein-Barr virus DNA quantification and prompt corticosteroid and antiviral therapy when viral load is high.


From the Departments of Internal Medicine (Drs van Laar and Deinum), Pediatrics (Drs Buysse and Hjálmarsson), Virology (Dr Vossen), Pulmonary and Critical Care Medicine (Dr van den Berg), and Hematology (Dr van Lom), University Hospital Rotterdam, Rotterdam, the Netherlands.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fatal Epstein-Barr Virus Primo Infection in a 25-Year-Old Man Treated with Azathioprine for Crohn's Disease
N'Guyen et al.
J. Clin. Microbiol. 2009;47:1252-1254.
ABSTRACT | FULL TEXT  

Evaluation of the Epstein-Barr Virus R-Gene Quantification Kit in Whole Blood with Different Extraction Methods and PCR Platforms
Fafi-Kremer et al.
J. Mol. Diagn. 2008;10:78-84.
ABSTRACT | FULL TEXT  

Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment
Casper et al.
Blood 2004;103:1632-1634.
ABSTRACT | FULL TEXT  

Rabbit Model for Human EBV-Associated Hemophagocytic Syndrome (HPS): Sequential Autopsy Analysis and Characterization of IL-2-Dependent Cell Lines Established from Herpesvirus Papio-Induced Fatal Rabbit Lymphoproliferative Diseases with HPS
Hayashi et al.
Am. J. Pathol. 2003;162:1721-1736.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.